FDA Generic Labeling Reg Could Fuel Suits Against Brands As Well
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed rule’s 30-day deadline for adoption of a generic’s approved label change could set standard for following brand’s revision; brands could be sued for picking one generic label change over another.
You may also be interested in...
FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield
FDA proposed rule would allow ANDA holders to unilaterally make label changes prior to FDA’s approval; NDA and other ANDA holders would have 30 days to revise their labels once FDA approves the change.
J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision
Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.
Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA
Pfizer subsidiary to pay $490.9 million to resolve criminal and civil liability for marketing its immunosuppressive for unapproved uses; actions predate Pfizer’s 2009 corporate integrity agreement.